Cited by 218Hepatitis B Virus StudiesGut microbiota and healthLiver physiology and pathology

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

Open access

Chou, Han-Hsuan, Chien, Wei-Hung, Wu, Li-Ling, Cheng, Chi-Hung, Chung, Chen-Han, Horng, Jau-Haw, Ni, Yen-Hsuan, Tseng, Hong-Tai, Wu, Dafei, Lu, Xuemei, Wang, Hurng-Yi, Chen, Pei-Jer, Chen, Ding-Shinn·2015·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1424775112PMC PMC4343154

Open this paper in CoChat — free account

Abstract

Significance: Ninety-five percent of adult-acquired infections lead to spontaneous clearance, whereas >90% of exposed neonates and ∼30% of children aged 1–5 y fail to resolve hepatitis B virus (HBV) and develop chronic infection. A strong, diverse, adaptive immune response is considered essential for HBV clearance, but the mechanisms to generate a favorable response remain elusive. Here, we show that, while 12-wk-old C3H/HeN mice cleared HBV within 6 wk postinjection (wpi), their 6-wk-old counterparts remained HBV-positive at 26 wpi. Sterilization of gut microbiota from 6 to 12 wk of age using antibiotics prevented mice from rapidly clearing HBV. This model is valuable to the study of liver tolerance and enables the investigation of the mechanisms involved in effective control of HBV.

Integrity signals

Registry

Crossref · 10.1073/pnas.1424775112

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,361
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,066
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758 · cited 1×
“Liver sinusoid endothelial cells (LSECs) respond to Gram-negative bacteria-derived lipopolysaccharides (LPSs) through Toll-like receptor (TLR) 4 by the secretion of interleukin-10 (IL-10), which induces T-cell tolerance (17, 18).”
Background
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J. A., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.348 · Cited by 514
Tolerance of Infections
Ayres, J. S., & Schneider, D. S. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075030 · Cited by 475

Show all 34 references

Sorted by citations

Items 101–200 of 218

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes
Li, Y., Kang, N., Jiang, J., Zhu, Y., Liu, Y.-R., Zeng, D., & Wang, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i35.5188 · Cited by 17
Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
Zhou, Z., Pan, X., & Li, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1070208 · Cited by 19
The role of gut microbiota in hepatitis B disease progression and treatment
Chen, B., Huang, H. J., & Pan, C. Q. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13595 · Cited by 17
Who determines the outcomes of HBV exposure?
Wang, B., & Li, L. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.04.001 · Cited by 17
Antibiotic-associated Gut Dysbiosis
Ramakrishna, B., & Patankar, R. V. (2023) · Journal of the Association of Physicians of India · doi:10.59556/japi.71.0381 · Cited by 17
Decreased levels of serum zonulin and copeptin in chronic Hepatitis-B patients
Çalgın, M. K., & Çetinkol, Y. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.3.144 · Cited by 15
Gut Microbiota and Liver Injury (I)—Acute Liver Injury
Wu, G., Win, S., Than, T. A., Chen, P., & Kaplowitz, N. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_3 · Cited by 15
Self-citation
Dysbiosis and liver diseases (Review)
Nishikawa, H., Fukunishi, S., Asai, A., Yokohama, K., Ohama, H., Nishiguchi, S., & Higuchi, K. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5016 · Cited by 15
miR-146a Maintains Immune Tolerance of Kupffer Cells and Facilitates Hepatitis B Virus Persistence in Mice
Liu, Y., Qin, L., Wang, J., Xie, X., Zhang, Y., Li, C., Guan, Z., Qian, L., Chen, L., Hu, J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100618 · Cited by 16
Hydrodynamic HBV Transfection Mouse Model
Wu, L., Wang, H., & Chen, P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6700-1_19 · Cited by 15
Self-citation
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation
Saha, S., & Schnabl, B. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2450707 · Cited by 14
Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases
Singh, B., Qin, N., & Reid, G. (2016) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528114666160128150747 · Cited by 13
Structural and compositional segregation of the gut microbiota in HCV and liver cirrhotic patients: A clinical pilot study
Ullah, N., Kakakhel, M. A., KHAN, I. A., Hilal, M. G., Zha, L., Bai, Y., Sajjad, W., Yuxi, L., Ullah, H., Almohaimeed, H. M., et al. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105739 · Cited by 12
Gut microbes associated with functional cure of chronic hepatitis B
Honda, T., Ishigami, M., Ishizu, Y., Imai, N., Ito, T., Yamamoto, K., Yokoyama, S., Muto, H., Inukai, Y., Kato, A., et al. (2025) · Hepatology International · doi:10.1007/s12072-025-10776-9 · Cited by 12
Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients
Yu, F., Zhang, X., Tian, S., Geng, L., Xu, W., Ma, N., Wang, M., Jia, Y., Liu, X., Ma, J., et al. (2017) · Bioscience Reports · doi:10.1042/bsr20171263 · Cited by 12
Gut microbiota in the innate immunity against hepatitis B virus — implication in age-dependent HBV clearance
Wu, L., Huang, T., Shyu, Y., Wang, C.-L., Wang, H., & Chen, P. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.06.006 · Cited by 14
Self-citation
Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome
Zhang, S., Chau, H.-T., Tun, H. M., Huang, F., Wong, D. K.-H., Mak, L., Yuen, M., & Seto, W. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105101 · Cited by 11
Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma
Li, N., Zhu, Q., Yang, C., Li, F., Zhou, Z.-H., Lv, Y., Sang, J., Han, Q., & Liu, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-4423-x · Cited by 11
[Gut microbiota-an important contributor to liver diseases].
Wang, F., Cui, Q., Zeng, Y., & Peng, C. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.04.23 · Cited by 11
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
Torres-Cornejo, A., & Lauer, G. M. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i1.201 · Cited by 10
Unveiling the Important Role of Gut Microbiota and Diet in Multiple Sclerosis
Džidić-Krivić, A., Begagić, E., Hadžić, S., Bećirović, A., Bečirović, E., Hibić, H., Lihić, L. T., Vukas, S. K., Bečulić, H., Kasapović, T., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15030253 · Cited by 15
Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL‐HBV and REVEAL‐HCV cohort studies
Petrick, J. L., Florio, A. A., Zen, J., Wang, Y., Gewirtz, A. T., Pfeiffer, R. M., Loftus, S. A., Inglefield, J. R., Koshiol, J. E., Yang, B., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34492 · Cited by 10
A mouse model with age-dependent immune response and immune-tolerance for HBV infection
Yi, X., Yuan, Y., Li, N., Lü, Y., Wang, C., Qi, Y. C., Gong, L., Liu, G., & Kong, X. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.071 · Cited by 10
Gut Microbiota and Liver Injury (II): Chronic Liver Injury
Baker, S. S., & Baker, R. D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_4 · Cited by 10
Immune modulation of gut microbiota and its metabolites in chronic hepatitis B
Li, S.-Q., Shen, Y., Zhang, J., Weng, C., Wu, S., & Jiang, W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1285556 · Cited by 9
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease
Ma, L., Zhang, M., Xu, Y., Hao, Y.-X., Niu, X.-X., Li, Y., & Xing, H. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i28.105089 · Cited by 13
Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications
Singh, G., Ansari, S., Yadav, S., & Aran, K. R. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108273 · Cited by 10
A novel therapy targeting the gut–liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium
Xun, Z., Yao, X., Lin, C., Yang, X., Zhang, Y., Yang, X., He, Y., Jiang, R., Lan, Y., Ye, Y., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101456 · Cited by 8
Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics
Zhang, R., Lu, Z., Xu, Y., Peng, Q., Xiao, M., & Sang, S. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/5625222 · Cited by 9
Peyer's patch-involved gut microbiota facilitates anti-HBV immunity in mice
Li, Y., Zhong, S., Jin, Z., Ye, G., Zhang, T., Liu, Z., Liu, Z., Zeng, Z., Li, Q., Wang, Y., et al. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199129 · Cited by 8
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
Todorović, N., Martinelli, S., Nannini, G., Weiskirchen, R., & Amedei, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413510 · Cited by 8
Proliferation of CD11b+ myeloid cells induced by TLR4 signaling promotes hepatitis B virus clearance
Wang, Q., Zhang, H., Chen, Z., Chen, L., Pan, F., & Zhou, Q. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155867 · Cited by 8
Plasma virome dynamics in chronic hepatitis B virus infected patients
Thijssen, M., Tacke, F., Espen, L. V., Cassiman, D. M., Aldine, M. N., Nevens, F., Ranst, M. A. V., Matthijnssens, J., & Pourkarim, M. R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1172574 · Cited by 8
When Viruses Cross Developmental Pathways
Trivedi, P., Patel, S. K., Bellavia, D., Messina, E., Palermo, R., Ceccarelli, S., Marchese, C., Anastasiadou, E., Minter, L. M., & Felli, M. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691644 · Cited by 9
Gut microbiota links to histological damage in chronic HBV infection patients and aggravates fibrosis via fecal microbiota transplantation in mice
Wang, F., Wu, Y., Ni, J., Xie, Q., Shen, J. F., Chen, H., Ma, C., Yao, Y., Wang, J., Xu, L., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00764-25 · Cited by 7
Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
Pamela Thomson, M., Paulina Núñez, F., Quera, R., & Constanza Bay, M. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100898 · Cited by 7
Crosstalk between Gut Microbiota and Hepatocellular Carcinoma
Xie, C., & Pocha, C. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5020013 · Cited by 7
Traditional Chinese medicine invigorating the spleen and kidney promotes HBsAg seroclearance in the mouse model
Zeng, D., Chen, Z., Hong, M., Jiang, L., Chen, X., Xue, H., Pan, J., & Zhu, Y. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28979 · Cited by 8
High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection
Gu, S., Fu, X., Ye, G., Chen, C., Li, X., Zhong, S., Tang, L., Chen, H., Jiang, D., Hou, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649197 · Cited by 7
Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model
Bu, Y., Zhao, K., Xu, Z., Zheng, Y., Hua, R., Wu, C., Zhu, C., Xia, Y., & Cheng, X. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.04.010 · Cited by 7
Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis
Long, J., Saw, M., Zhang, P., Wang, L., Li, L., Ren, H., Liu, C., Ma, Z., Zhang, J., & Wang, B. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03457-4 · Cited by 6
Pathogenetic relationship between the condition gut microbiota and liver diseases
Ventslovayte, N. D., Goryacheva, L. G., Гончар, Н. В., Александровна, Г. В., & Александровна, Е. Н. (2022) · Infectious diseases News Opinions Training · doi:10.33029/2305-3496-2022-11-2-97-105 · Cited by 6
Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺
Haque, M., Lei, F., Xiong, X.-F., Ren, Y.-J., Kumar, A., Das, J., Ren, X.-C., Fang, D., de Figueiredo, P., Yang, J.-M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101333 · Cited by 6
Modeling Hepatotropic Viral Infections: Cells vs. Animals
Rad, N. K., Zahmatkesh, E., Bikmulina, P., Peshkova, M., Kosheleva, N. V., Bezrukov, E. A., Sukhanov, R. B., Solovieva, A., Shpichka, A. I., Timashev, P. S., et al. (2021) · Cells · doi:10.3390/cells10071726 · Cited by 6
A new hepatitis B virus e antigen-negative strain gene used as a reference sequence in an animal model
Cao, M., Zhao, Z., Tang, Y., Wei, Q., Wang, L., Xiang, Q., Zhang, Y., Zhang, H., & Lai, G. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.081 · Cited by 6
Changes in the gut microbiome can predict and decrease Epstein‐Barr virus infection risk in children after liver transplantation
Wang, X., Sun, L., Li, P., & Zhang, S. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14114 · Cited by 5
Chronic hepatitis B virus infection imbalances short-chain fatty acids and amino acids in the liver and gut via microbiota modulation
Zhang, W., Wu, Y., Cheng, M., Wei, H., Sun, R., Peng, H., Tian, Z., & Chen, Y. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00695-3 · Cited by 8
Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy
Zeng, Y., Qin, L., Wei, W., Cai, H., Yu, X., Zhang, W., Wu, X., Liu, X., Chen, W.-M., You, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82939-1 · Cited by 5
Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
Long, J., Gong, J., Zhu, H., Liu, X., Li, L., Chen, B., Ren, H., Liu, C., Lu, H., Zhang, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1232180 · Cited by 5
Viral Liver Disease and Intestinal Gut–Liver Axis
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6010005 · Cited by 5
High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice
Wen, J., Chen, G., Wang, T., Wan, Y., Liu, Z., & Wang, H. (2024) · Comparative Medicine · doi:10.30802/aalas-cm-23-000050 · Cited by 5
Self-citation
RETRACTED: Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta‐analysis
Jiang, J., & Ren, F. (2024) · International Wound Journal · doi:10.1111/iwj.14838 · Cited by 7
Retracted
Altered gut microbiota is associated with the formation of occult hepatitis B virus infection
Liu, B., Hualong, Y., Liao, Q., Wang, M., Huang, J., Xu, R., Shan, Z., Zhong, H., Li, T., Li, C., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00239-24 · Cited by 5
Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors
Sagnelli, C., & Sagnelli, E. (2019) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v9.i2.11 · Cited by 5
Gut Microbiota and Health
Zhang, C., Virk, A. K., KHAN, I. A., & Qin, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-4759-1_2 · Cited by 5
iPSCs for modeling hepatotropic pathogen infections
Bove, G., Mehnert, A.-K., & Thi, V. L. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00013-4 · Cited by 4
The role of intestinal microbiota, bile acids, and Th17/IL17 axis in hepatitis B virus-related liver fibrosis
Chen, Y., Chen, J., & Li, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001199 · Cited by 4
Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota
Lou, J., Ren, Z., Li, A., Rao, B., & Yu, Z. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2019.12.008 · Cited by 4
Fatty liver checkmates hepatitis B virus
Ramakrishna, G., & Trehanpati, N. (2018) · Hepatology International · doi:10.1007/s12072-018-9903-9 · Cited by 4
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Yu, J. H., & Lee, J. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0104 · Cited by 4
Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances
Zhang, J., Lou, T., Zhu, M., Wang, C., Gong, K., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603544 · Cited by 3
Gut Microbiota and Gut-Brain Axis in Health and Disease A Narrative Review
Wasiak, J., Zielonka, K., Dądela, B., Markowski, M., Śliwa, N., Majewska, E. M., Kawalska, E., Gnitecki, S., Janczura, S., & Borowski, M. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60102 · Cited by 3
Novel hepatitis B virus infection mouse model using herpes simplex virus type 1 thymidine kinase transgenic mice
Kanbe, A., Ishikawa, T., Hara, A., Suemizu, H., Nanizawa, E., Tamaki, Y., & Ito, H. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15142 · Cited by 3
Risk factors for de novo hepatitis B during solid cancer treatment
Sugimoto, R., Furukawa, M., Senju, T., Aratake, Y., Shimokawa, M., Tanaka, Y., Inada, H., Noguchi, T., Lee, L., Miki, M., et al. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i24.6264 · Cited by 3
A Mendelian randomization study investigating causal links between gut microbiota or metabolites and chronic hepatitis B
Xing, T., Wang, X., & He, S. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1398254 · Cited by 4
Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)
Mir, G. J., & Ashraf, N. U. (2024) · The International Journal of Gastroenterology and Hepatology Diseases · doi:10.2174/0126662906299478240614100954 · Cited by 2
Effects of Probiotics on Liver Diseases: Current In Vitro and In Vivo Studies
Sadri, M., Shafaghat, Z., Roozbehani, M., Hoseinzadeh, A., Mohammadi, F., Arab, F. L., Minaeian, S., Fard, S. R., & Faraji, F. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10431-z · Cited by 5
Exploring the association between pro-inflammatory diets and chronic liver diseases: evidence from the UK Biobank
Pan, L., Xu, Z. N., Li, Y., Cai, G., Gao, H., & Lin, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1537855 · Cited by 2
Die intestinale Mikrobiota als Ansatz für individuelle Therapien
Witte, T., Pieper, D. H., & Heidrich, B. (2017) · Der Internist · doi:10.1007/s00108-017-0259-3 · Cited by 3
Microbiota and Liver Cancer
Wu, C., & Tseng, C. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_5 · Cited by 2
The Gut Microbiome and Liver Disease
Yu, L., Bajaj, J. S., & Schwabe, R. F. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch84 · Cited by 1
Matrine and oxymatrine; natural products with antiviral potentials
Charoghdoozi, K., Khoshniat, A., Eskandarifar, A., Sadeghi, M., Eshaghi, S., Dehnavi, S., & Mohammadi, M. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107019 · Cited by 1
Other Precipitating Factors for AECHB
Wang, B., Guo, J., Li, L., Chen, T., Guo, C., & He, Y.-W. (2019) · Springer eBooks · doi:10.1007/978-94-024-1606-0_6 · Cited by 1
Fecal Microbiota Transplantation Slows the Progression of HBV-Related Liver Diseases and Induces Virologic Response in Patients with HBV Infection
Guo, Q., S-S, H., Li, J., Tian, Y., Zhou, Y., & X-A, L. (2021) · Austin Journal of Gastroenterology · doi:10.26420/austinjgastroenterol.2021.1117 · Cited by 1
Gut Microbiota and Antibiotics: Dysbiosis and Antimicrobial Resistance
Imchen, M., Moopantakath, J., & Kumavath, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00049-8 · Cited by 1
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
Kim, W. K. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0101 · Cited by 1
Study on the Characteristics of Gut Microbiota in Chronic Hepatitis B Patients With Damp Heat Syndrome and Liver Depression and Spleen Deficiency SyndromePreprint
Jiang, K., Jiang, Q., Mo, X., Li, J., Hu, H., Huang, Q., Guo, W., Qiu, T., Ren, J., Zhang, L., et al. (2020) · doi:10.21203/rs.3.rs-65426/v1 · Cited by 1
Author response: Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination
Elias, G., Meysman, P., Bartholomeus, E., Neuter, N. D., Keersmaekers, N., Suls, A., Jansens, H., Souquette, A. H., Reu, H. D., Emonds, M., et al. (2021) · eLife · doi:10.7554/elife.68388.sa2 · Cited by 1
Hepatitis B-infected pregnant women & their newborns: Implement knowledge in your community
van Leeuwen, D. J., & Meharry, P. M. (2022) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_1490_22 · Cited by 1
Impact de souches commensales et probiotiques d'Escherichia coli sur la physiopathologie de l'hôte
Escribano-Vázquez, U. (2018) · theses.fr (ABES) · doi:10.70675/ae439ff5z4d13z4af2za21az2572e5749b15 · Cited by 1
Gut Microbiota and Control of HBV Infection
Ellison, R. T. (2015) · Journal watch · doi:10.1056/nejm-jw.na37230
Epidemiology, Prevention and Control of Hepatitis B virus Infection in China
Qin, B., Zhou, G., & Dong, X. (2016) · Research and Reviews: Journal of Microbiology and Biotechnology
EFFECT BY INTESTINAL MICROBIOM ON THE PROGRESSION OF VIRAL HEPATITIS
Поліщук, Н. М., & Kamyshny, A. М. (2017) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2016-4-325-334
Exploring New Therapies for a Serological Cure of Chronic Hepatitis B
Horng, J.-H., Wu, C., & Chen, P. (2017) · Springer eBooks · doi:10.1007/978-981-10-4843-2_17
Self-citation
Immunology of Infectious Processes
Васильевич, K. В. (2019) · Springer eBooks · doi:10.1007/978-3-030-03323-1_7
Research progress on human microecology and infectious diseases
Bai, L., & He, W. (2018) · Infection International/Infection International (Electronic Edition) · doi:10.2478/ii-2018-0027
Natural History of Hepatitis B Virus Infection: From Infancy to Adult Life
Wu, J., & Ni, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-0050-9_7
Self-citation
固形腫瘍におけるde novo B型肝炎再活性化の頻度とタイミング，原疾患とリスク因子
杉本理恵, 千住猛士, & 荒武良総 (2020) · Kanzo · doi:10.2957/kanzo.61.230
Standardized Nursing Procedures for Fecal Microbiota Transplantation via Upper Endoscopy
Feng, J., Tang, Y., Zhou, L., & Pan, J. (2021) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000577
GUT MICROBIOTA IN THE PATHOLOGY AND PREVENTION OF LIVER DISEASE
Kharchenko, Y., Дичко, Є. Н., Topka, E. G., Kosse, V. A., Lyulko, I. V., Alekseenko, Z. K., & Filippov, Y. O. (2021) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2021-3-161-81-89
Using adeno-associated viral vectors to model HBV subgenotype A1 replication in cell culture and in vivo
Limani, S. W. (2021)
Study on the Characteristics of Gut Microbiota in Chronic Hepatitis B Patients with Damp Heat Syndrome and Liver Depression and Spleen Deficiency SyndromePreprint
Jiang, K., Jiang, Q., Mo, X., Li, J., Hu, H., Huang, Q., Guo, W., Qiu, T., Ren, J., Zhang, L., et al. (2020) · doi:10.21203/rs.3.rs-45025/v1
From inflammation to fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00010-x
Immunological paradox for maintaining normal flora: it is all by design, not by chance
Mehtani, D., & Puri, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96128-8.00002-x
Development and Characterization of a Chronic Hepatitis B Murine Model With a Mutation in the START Codon of an HBV Polymerase
Vaneková, L., Polidarova, M. P., CHARVAT, V., Vavřina, Z., Veverka, V., Birkuš, G., & Brázdová, A. (2023) · Physiological Research · doi:10.33549/physiolres.934979
Integration of Bidirectional Long Short-Term Memory (Bilstm) and Two-Dimensional Convolutional Neural Networks (CONV2D) for Improved Hepatitis A and B Prediction
Sharon, O. D. (2024) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.5.0124.0122
Role of Tenofovir dipivoxil in gut microbiota recovery from HBV- infection induced dysbiosisPreprint
Long, J., Saw, M., Zhang, P., Wang, L., Li, L., Ren, H., Liu, C., Ma, Z., Zhang, J., & Wang, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3855916/v1
in-text ref citation test High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice
Wen, J., Chen, G., Wang, T., Wan, Y., Liu, Z., & Wang, H. (2024) · Comparative Medicine · doi:10.30802/aalas-cm-23-000050.test1
Self-citation
Pitfalls in HBV Treatment and Management
Umutesi, J., Serumondo, J., & Muvunyi, C. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005795
Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected?
Lumley, S., Parker, E. L., Prendergast, A. J., & Matthews, P. C. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004984

Authors: Chou, H.-H., Chien, W.-H., Wu, L.-L., Cheng, C.-H., Chung, C.-H., Horng, J.-H., Ni, Y.-H., Tseng, H.-T., Wu, D., Lu, X., Wang, H.-Y., Chen, P.-J., & Chen, D.-S.
Affiliations: National Taiwan University (TW)
Chinese Academy of Sciences (CN)
ORCID: Wu, Li-Ling
Ni, Yen-Hsuan
Lu, Xuemei
Wang, Hurng-Yi
Chen, Pei-Jer
Chen, Ding-Shinn
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2015-02-02
Volume: 112
Issue: 7
Pages: 2175-2180
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1424775112
PMC: PMC4343154
OpenAlex: W2143865587
Cited by: 211
References: 34
Citations by year: 2026: 5 · 2025: 18 · 2024: 19 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 14 · 2017: 21 · 2016: 10 · 2015: 11
FWCI: 14.65
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: hepatitis B virus, viral clearance, age-related immunity, gut microbiota, TLR4, antibiotic-induced microbiota depletion, liver immunity, immune tolerance, C3H/HeN mice, C3H/HeJ mice
MeSH terms: Animals, Hepatitis B, Humans, Intestines, Mice, Inbred BALB C, Mice, Inbred NOD, Mice, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks